Dr. Firpi-Morell is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1600 Sw Archer Rd
MSB M440, Liver Unit
Gainesville, FL 32610Phone+1 352-273-9400Fax+1 352-392-7393
Education & Training
- Cedars-Sinai Medical CenterFellowship, Gastroenterology, 2001 - 2002
- University of FloridaFellowship, Gastroenterology, 1998 - 2001
- University of Puerto RicoResidency, Internal Medicine, 1994 - 1998
- University of Puerto Rico School of MedicineClass of 1994
Certifications & Licensure
- CA State Medical License 2001 - 2025
- FL State Medical License 1999 - 2025
- PR State Medical License 2004 - 2019
- American Board of Internal Medicine Gastroenterology
- American Board of Internal Medicine Transplant Hepatology
Awards, Honors, & Recognition
- Director of Hepatology University of Florida, 2009
- Medical Director, Liver Transplant University of Florida, 2009
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Cyclosporine in Hepatitis C Infection Viral Clearance Following Liver Transplantation Start of enrollment: 2004 Jun 01
- Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment Start of enrollment: 2015 Sep 22
Publications & Presentations
PubMed
- 109 citationsPerformance of Plasma Biomarkers and Diagnostic Panels for Nonalcoholic Steatohepatitis and Advanced Fibrosis in Patients With Type 2 Diabetes.Fernando Bril, Michael J. McPhaul, Michael P. Caulfield, Virginia Clark, Consuelo Soldevilla-Pico
Diabetes Care. 2020-02-01 - 14 citationsAsymptomatic primary biliary cirrhosis is not associated with increased frequency of cardiovascular diseaseIliana Doycheva, C. Chen, Jen Jung Pan, Cynthia Levy
World Journal of Hepatology. 2011-04-27 - 94 citationsTreatment outcomes and prognostic factors of intrahepatic cholangiocarcinomaRenumathy Dhanasekaran, Alan W. Hemming, Ivan Zendejas, Thomas J. George, David R. Nelson
Oncology Reports. 2013-04-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: